Funds and prices
Overview
The actively managed fund aims to achieve capital appreciation and provide income by investing primarily in debt securities issued in developed and emerging markets globally, including onshore China.
Seeks diversified income sources across a broad variety of sub-asset classes, sectors, geographical exposures, ratings and issuers.
Dynamically adjusts asset allocations to capture opportunities throughout the credit cycle while managing duration based on market conditions.
The fund leverages the expertise of ÃÛ¶¹ÊÓƵ GWM CIO to construct the asset allocations.
This fund is not managed in reference to any benchmark.
The exchange rate risk between USD and EUR is largely hedged.
Benefits
The fund seeks global credit market opportunities while providing access to the newly opened up onshore China market. The fund benefits from the diversification across geography, sub-asset class and issuer to mitigate risks such as liquidity and defaults.
The flexible duration management allows portfolio managers to protect capital in rising rate environments or increase returns in anticipation of falling yields.
The investment strategy is managed by experienced team with extensive expertise drawing on local presence and knowledge of sector specialist teams located in Asia, onshore China, the US and Europe that other managers may not have access to.
Risks
Features
Product category |
Bond
Corporates |
Product domicile |
Luxembourg
|
Portfolio management |
ÃÛ¶¹ÊÓƵ Asset Management (Hong Kong) Ltd., Hong Kong
|
Fund management |
ÃÛ¶¹ÊÓƵ Fund Management (Luxembourg) S.A., Luxembourg
|
Custodian bank |
ÃÛ¶¹ÊÓƵ Europe SE, Luxembourg Branch
|
Representative for products established under foreign law |
ÃÛ¶¹ÊÓƵ Fund Management (Switzerland) AG
|
Day of inception |
March 25, 2021
|
Currency of account |
EUR
|
Close of financial year |
September 30
|
Issue / redemption |
daily
|
Maturity |
Open end
|
Management fee |
0.00% p.a.
|
Total expense ratio (TER) |
0.24% p.a.
|
Minimum investment |
n.a.
|
Cut-Off Time |
10:00h (CET)
|
Securities no. |
110322085
|
ISIN |
LU2310811604
|
Bloomberg Ticker |
UBIOUIB LX
|
Performance and Prices
Percentage growth
as of April 2, 2024EUR(%) | CHF(%) | USD(%) | |
YTD | 1.40 | 6.41 | -1.17 |
1M | |||
3M | |||
6M | |||
1Y | |||
2Y | 5.35 | -0.80 | 9.04 |
3Y | -12.37 | -22.93 | -19.78 |
5Y | |||
ø p.a.5Y | -4.31 | -8.32 | -7.08 |
Current data
Net asset value | 03.04.2024 | EUR 76.75 |
High - last 12 months | 14.04.2023 | EUR 77.46 |
Low - last 12 months | 01.12.2023 | EUR 73.86 |
Last distribution | 06.12.2023 | EUR 3.64 |
Assets of the unit class in mn | 03.04.2024 | EUR 25.79 |
Total product assets in mn | 03.04.2024 | EUR 134.78 |
Structures
By the 10 largest positions (in %, as of February 29, 2024)
|
|
China Government Bond | 2.63 |
Us Treasury | 2.06 |
Ind & Comm Bk Of China | 0.96 |
Standard Chartered Plc | 0.91 |
Bank Of China | 0.75 |
Republic Of Sri Lanka | 0.73 |
Altice France Sa | 0.71 |
Republic Of Philippines | 0.71 |
Nidda Healthcare Holding | 0.71 |
China Development Bank | 0.68 |
Fees
Distributions
Date of distribution
|
Pay date
|
Cps no.
|
Currency
|
Distribution
|
01.12.2023 | 06.12.2023 | 3 | EUR | 3.64 |
Authorisations
Literature
Document type
|
Document Language
|
|||
Prospectus |
|
|
||
Key Information Document |
|
|
|
|
Past performance |
|
|
|
|
Previous performance scenario |
|
|
|
|
Statutes / Management regulations |
|
|
Document type
|
Document Language
|
||
Annual report |
|
|
|
Semi-annual report |
|
|
|